Israeli early-stage investment firm NGT3 is preparing to roll out a second fund as it looks to step up its bets on life sciences and medical devices companies, a top executive told The Capital Quest. Zohar Gendler, managing partner and chief executive officer at the Nazareth, Israel-based fund, said that […]
